2Withering W. An account of the foxglove and some of its medical uses, with practical remarks on dropsy, and other diseases. In: Willins FA, Keys TE. eds. Classics of Cardiology(Vol1) .New York: Henry Schuman, Dover Publications, 1941 :231 - 252.
3Goldsmith SR, Miller E, Effect of digitalis on norepinephrine kinetics in congestive heart failure.J Am Coil Cardiol, 1992,20 : 858-863.
4Ramahi TM, Lee FA. Medical therapy and prognosis in chronic heart failure: Lessons from clinical trials. Cardiol Clin, 1995,13 : 5- 26.
5Remme WJ. Inotropic agents for heart failure: What if digoxin increases mortality?Br Heart J(suppl), 1994, 72 : 92- 99.
6Ferguson DW.Digitalis and neurohormonal abnormalities in heart failure and implication for therapy. Am J Cardiol, 1992,69 : 24G - 33G.
7Brouwer J, Veldhuisen DJ.Heart rate variability in patient with mild to moderate heart failure: Effects of neurohormonal modulation by digoxin and ibopamine. J Am Coil Cardiol, 1995,26 : 983- 990.
8Veldhuisen DJ, Brouwer J, Man AJ, et al. Progression of mild untreated heart failure during six months follow-up and clinical and neurohumoral effects of ibopamine and digoxin asmonotherapy. Am J Cardiol, 1995, 75 : 796- 800.
9Lloyd MA, Sandberg SM, Edwards BS, Role of renal Na +K + -ATP ase in the regulation of sodium excretion under normal condition and in acute congestive heart failure. Circulation,1992, 85 : 1912- 1917.
10Covit AB, Schaer GL, Sealey JE, et al. Suppression of the reninangiotensin system by intravenous digoxin in chronic congestive heart failure. Am J Med, 1983, 75 : 445- 447.
